Characterisation of Neisseria gonorrhoeae in semen during urethral infection in men

Genitourinary Medicine

Volumn 73, Issue 5, 1997, Pages 378-382

  Isbey, Susan F ^a   Alcorn, Timothy M ^a   Davis, Rachael H ^a   Haizlip, Julie ^a   Leone, Peter A ^a   Cohen, Myron S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Gonorrhoea; Neisseria gonorrhoeae; Semen

Indexed keywords

ADULT; ARTICLE; BACTERIAL OUTER MEMBRANE; CLINICAL ARTICLE; GONORRHEA; HUMAN; MALE; MALE GENITAL TRACT INFECTION; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; SEMEN ANALYSIS; SEXUALLY TRANSMITTED DISEASE; URETHRITIS; URINALYSIS;

EID: 0030670523     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.73.5.378     Document Type: Article

References (30)

1. Hook EW III, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Mardh PA, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases. New York: McGraw-Hill, 1990:149-65.
2. Webster LA, Berman SM, Greenspan JR. Surveillance for gonorrhea and secondary syphilis among adolescents, United States-1981-1991. MMWR 1993;42(SS-3):1-11.
3. World Health Organisation. An overview of selected curable sexually transmitted diseases. Geneva: WHO Global Programme on AIDS, 1995.
4. Holmes KK, Eschenbach DA, Knapp JS. Salpingitis: overview of etiology and epidemiology. Am J Obstet Gynecol 1980;138:893-900.
5. Eschenbach DA, Buchanan TM, Pollock HM, Forsyth PS, Alexander ER, Lin JS, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 1975;293:166-71.
6. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102.
7. Royce RA, Sena A, Gates W, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-9.
8. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press, 1991.
9. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970;91:170-4.
10. Hooper JJ, Reynolds GH, Jones OG, Zaidi A, Wiesner PJ, Latimer KP, et al. Cohort study of venereal disease. I The risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978;108:136-44.
11. Mahoney JF, Van Slyke CJ, Cutler JC, Blum HL. Experimental gonococcal urethritis in human volunteers. Am J Syph Gonorrhea Vener Dis 1946;30:1-39.
12. Cohen MS, Cannon JG, Jerse AE, Charniga LM, Isbey SF, Whicker LG. Human experimentation with Neisseria gonorrhoeae: rationale, methods and implications for the biology of vaccine development. J Infect Dis 1994;169:532-7.
13. Schneider H, Cross AS, Kuschner RA, Taylor DN, Sadoff JC, Boslego JW, et al Experimental human gonococcal urethritis 250: Neisseria gonorrhoeae MS11 mkC are infective. J Infect Dis 1995;172:180-5.
14. Cohen MS, Sparling PF. Mucosal infection with Neisseria gonorrhoeae: bacterial adaptation and mucosal defenses. J Clin Invest 1992;89:1699-705.
15. Haizlip J, Isbey SF, Hamilton HA, Jerse AE, Leone PA, Davis RH, et al. Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy. Sex Transm Dis 1995;22:145-8.
16. Black WJ, Schwalbe RS, Nachimkin I, Cannon JG. Characterization of Neisseria gonorrhoeae protein II phase variation by use of monoclonal antibodies. Infect Immun 1984;45:453-7.
17. Jerse AE, Cohen MS, Drown PM, Whicker LG, Isbey SF, Seifert HS, et al. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J Exp Med 1994;179:911-20.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
19. Lambden PR, Heckels JE. Outer membrane protein composition and colonial morphology of Neisseria gonorrhoeae strain P9. FEMS Microbiol Lat 1979;5:263-5.
20. Tsai C-M, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 1982;119:115-9.
21. Hitchcock PJ, Brown TM. Morphological heterogeneity among salmonella lipopolysaccharide chemotype in silver stained polyacrylamide gels. J Bacteriol 1983;154:269-77.
22. Campagnari AA, Spinola SM, Lesse AJ, Kwaik YA, Mandrell RE, Apicella MA. Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens. Microb Path 1990;8:353-62.
23. Weel JF, Hopman CT, van Putten JPM. In situ expression and localization of Neisseria gonorrhoeae opacity proteins in infected epithelial cells: apparent role of Opa proteins in cellular invasion. J Exp Med 1991;173:1395.
24. Schneider H, Griffiss JM, Boslego JW, Hitchcock PJ, Zahos KM, Apicella MA. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J Exp Med 1991;174:1601-6.
25. Swanson JK, Robbins K, Barerra O, Corwin J, Boslego J, Ciak M, et al. Gonococcal pilin variants in experimental gonorrhea. J Exp Med 1987;165:1344-57.
26. Lowe TL, Kraus SJ. Quantitation of Neisseria gonorrhoeae from women with gonorrhea. J Infect Dis 1976;133:621-6.
27. Schwalbe RS, Sparling PF, Cannon JG. Variation of Neisseria gonorrhoeae protein II among isolates from an outbreak caused by a single gonococcal strain. Infect Immun 1985;49:250-2.
28. Cohen MS, Dallabetta G, Laga M, Holmes KK. A new deal in HIV prevention: lessons from the global approach. Ann Intern Med 1994;120:340-1.
29. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkorro K, et al. Impact of improved sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trials. Lancet 1995;346:530-6.
30. The Jordan Report, 1993. Accelerated development of vaccines. Bethesda, MD: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health.